AGP Executive Report
Last update: 9 hours agoCardio–Kidney Link: The European Society of Cardiology and the European Renal Association released Europe’s first joint guidelines on managing cardiovascular disease alongside chronic kidney disease, urging earlier kidney checks in heart patients to break the “two-way” cycle that raises events and earlier dialysis. Sleep & Digestive Health: New genetic research suggests insomnia and unusual sleep patterns may raise the risk of hemorrhoidal disease, pushing sleep advice further into everyday GI care. Alzheimer’s Prevention Trial: The NHS is set to offer a new Alzheimer’s drug (Trontinemab) to symptom-free people at high risk in a Europe-unique trial using blood testing for a predictive biomarker. Cancer Care Advances: At ProsTIC, researchers discussed moving PSMA-targeted radioligand therapy earlier in high-risk localized prostate cancer, plus updates on PSMA imaging and theranostics in China. Medication Adherence Warning (UK): Reports highlight that many people on blood pressure tablets don’t take them as prescribed, often due to side effects—raising the stakes for safer, tolerable treatment plans. Food Safety Red Flag: “Aphrodisiac honey” sold as organic has been found adulterated with Viagra-type drugs, with experts warning about dangerous blood-pressure drops, especially with alcohol. EU Humanitarian Aid: The EU sent a first air-bridge flight to Nepal with 82 tonnes of supplies, including nutrition, health, water and sanitation, after floods. Breast Screening AI (Germany): Regulators granted Vara CE-mark approval for autonomous triage of normal mammograms, aiming to ease radiologist shortages while keeping human review for complex cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.